Clinical trial
Study of the in Vivo Expression of MU Opioid Receptors Using PET and the Selective Tracer [C-11] Carfentanil in Normal Weight and Obese Subjects
NCT06180200 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the in Vivo Expression of MU Opioid Receptors Using PET and the Selective Tracer [C-11] Carfentanil in Normal Weight and Obese Subjects
- Lead sponsor
- IRCCS San Raffaele
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 22, 2004
- Completion date
- December 1, 2007
- Enrollment
- 16 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
nuclear medicine